Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques
- PMID: 8139022
- PMCID: PMC236713
- DOI: 10.1128/JVI.68.4.2362-2370.1994
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques
Abstract
Infection of the rhesus monkey with simian immunodeficiency virus of macaques (SIVmax) was employed to explore the early immune events associated with the initial containment of an acute AIDS virus infection. In nine rhesus monkeys infected intravenously with uncloned SIVmac strain 251, high-level p27 plasma antigenemia was usually detected transiently from approximately day 7 through day 21 following virus inoculation. SIVmac replication in lymph nodes measured by in situ RNA hybridization closely paralleled the time course and magnitude of viremia. The containment of SIVmac spread by 3 to 4 weeks following infection suggests an efficient, early immune control of this virus infection. Anti-SIVmac antibodies were first detected in the blood at approximately day 14. At the time antigenemia was decreased or cleared, SIVmac neutralizing antibodies were present. A rise in circulating and lymph node CD8+ T cells also occurred coincident with the clearance of antigenemia and persisted thereafter. These CD8+ lymphocytes in lymph nodes had increased expression of both major histocompatibility complex class II and the adhesion molecule LFA-1; they also demonstrated decreased expression of the naive T-cell-associated CD45RA molecule. SIVmac-specific cytotoxic T-lymphocyte precursors were detected in both blood and lymph node by 7 days post-virus inoculation. These studies indicate that both virus-specific humoral and cellular immune mechanisms in blood and lymph node are associated with the clearance of viremia that occurs within the first month of infection of rhesus monkeys with SIVmac.
Similar articles
-
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.J Virol. 1993 Mar;67(3):1707-11. doi: 10.1128/JVI.67.3.1707-1711.1993. J Virol. 1993. PMID: 8437240 Free PMC article.
-
Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.J Virol. 1999 Feb;73(2):1573-9. doi: 10.1128/JVI.73.2.1573-1579.1999. J Virol. 1999. PMID: 9882363 Free PMC article.
-
T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.J Exp Med. 1995 Jul 1;182(1):21-31. doi: 10.1084/jem.182.1.21. J Exp Med. 1995. PMID: 7540651 Free PMC article.
-
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys.Blood. 2000 Aug 15;96(4):1474-9. Blood. 2000. PMID: 10942394
-
Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.Semin Immunol. 1993 Jun;5(3):215-23. doi: 10.1006/smim.1993.1025. Semin Immunol. 1993. PMID: 8394161 Review.
Cited by
-
Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.Vaccine. 2016 Oct 17;34(44):5344-5351. doi: 10.1016/j.vaccine.2016.08.089. Epub 2016 Sep 12. Vaccine. 2016. PMID: 27633665 Free PMC article.
-
Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.J Virol. 2000 Aug;74(16):7400-10. doi: 10.1128/jvi.74.16.7400-7410.2000. J Virol. 2000. PMID: 10906193 Free PMC article.
-
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.J Virol. 1996 Sep;70(9):6199-206. doi: 10.1128/JVI.70.9.6199-6206.1996. J Virol. 1996. PMID: 8709246 Free PMC article.
-
An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes.Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7501-5. doi: 10.1073/pnas.91.16.7501. Proc Natl Acad Sci U S A. 1994. PMID: 7914369 Free PMC article.
-
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.J Exp Med. 1997 Mar 3;185(5):909-20. doi: 10.1084/jem.185.5.909. J Exp Med. 1997. PMID: 9120397 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials